News summarySeeking AlphaNov 10, 2026, 11:54 AM
Protalix BioTherapeutics beats top-line and bottom-line estimates; reaffirms FY26 outlook
Protalix BioTherapeutics beats top-line and bottom-line estimates; reaffirms FY26 outlook(摘要待生成)
Loading...
Protalix BioTherapeutics beats top-line and bottom-line estimates; reaffirms FY26 outlook(摘要待生成)